FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a Nasdaq Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments to Create Medical Cannabis Industry...

CSE: HUGE
OTCQB: FSDDF
FRA: 0K9

  • Transaction combines two highly complementary businesses; the significant production and distribution of medical and recreational products by FSD Pharma, and the premium and differentiated medical and......
    . .
    Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Tuesday, 23 October
Share |